MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/eurheartj/suy019

Медицинская библиотека · European heart journal supplements : journal of the European Society of Cardiology · 2018

Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease.

Gulizia Michele Massimo, Colivicchi Furio, Abrignani Maurizio Giuseppe, Ambrosetti Marco, Aspromonte Nadia, Barile Gabriella, Caporale Roberto, Casolo Giancarlo, Chiuini Emilia, Di Lenarda Andrea, Faggiano Pompilio, Gabrielli Domenico, Geraci Giovanna, La Manna Alessio Gaetano, Maggioni Aldo Pietro, Marchese Alfredo, Massari Ferdinando Maria, Mureddu Gian Francesco, Musumeci Giuseppe, Nardi Federico, Panno Antonio Vittorio, Pedretti Roberto Franco Enrico, Piredda Massimo, Pusineri Enrico, Riccio Carmine, Rossini Roberta, di Uccio Fortunato Scotto, Urbinati Stefano, Varbella Ferdinando, Zito Giovanni Battista, De Luca Leonardo, ESC Scientific Document Group, Faculty for approval of the Consensus Document

СтатьяПеревод пока не подготовлен

Аннотация

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is the cornerstone of pharmacologic management of patients with acute coronary syndrome (ACS) and/or those receiving coronary stents. Long-term (>1 year) DAPT may further reduce the risk of stent thrombosis after a percutaneous coronary intervention (PCI) and may decrease the occurrence of non-stent-related ischaemic events in patients with ACS. Nevertheless, compared with aspirin alone, extended use of aspirin plus a P2Y12 receptor inhibitor may increase the risk of bleeding events that have been strongly linked to adverse outcomes including recurrent ischaemia, repeat hospitalisation and death. In the past years, multiple randomised trials have been published comparing the duration of DAPT after PCI and in ACS patients, investigating either a shorter or prolonged DAPT regimen. Although the current European Society of Cardiology guidelines provide a backup to individualised treatment, it appears to be difficult to identify the ideal patient profile which could safely reduce or prolong the DAPT duration in daily clinical practice. The aim of this consensus document is to review contemporary literature on optimal DAPT duration, and to guide clinicians in tailoring antiplatelet strategies in patients undergoing PCI or presenting with ACS.

Для цитирования: Gulizia Michele Massimo, Colivicchi Furio, Abrignani Maurizio Giuseppe, Ambrosetti Marco, Aspromonte Nadia, Barile Gabriella, Caporale Roberto, Casolo Giancarlo, Chiuini Emilia, Di Lenarda Andrea, Faggiano Pompilio, Gabrielli Domenico, Geraci Giovanna, La Manna Alessio Gaetano, Maggioni Aldo Pietro, Marchese Alfredo, Massari Ferdinando Maria, Mureddu Gian Francesco, Musumeci Giuseppe, Nardi Federico, Panno Antonio Vittorio, Pedretti Roberto Franco Enrico, Piredda Massimo, Pusineri Enrico, Riccio Carmine, Rossini Roberta, di Uccio Fortunato Scotto, Urbinati Stefano, Varbella Ferdinando, Zito Giovanni Battista, De Luca Leonardo, ESC Scientific Document Group, Faculty for approval of the Consensus Document. Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease.. European heart journal supplements : journal of the European Society of Cardiology. 2018. DOI: 10.1093/eurheartj/suy019.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.